Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Timothy Garrington

Concepts (322)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Central Nervous System Neoplasms
2
2024
158
0.710
Why?
Rhabdomyosarcoma
1
2019
72
0.580
Why?
Sarcoma, Ewing
3
2025
95
0.570
Why?
MAP Kinase Kinase Kinases
6
2004
73
0.530
Why?
Kidney Neoplasms
4
2025
400
0.500
Why?
Mitogen-Activated Protein Kinases
8
2004
313
0.410
Why?
Hodgkin Disease
2
2016
139
0.390
Why?
Wilms Tumor
2
2025
86
0.350
Why?
Neuroblastoma
3
2017
160
0.330
Why?
Mitogen-Activated Protein Kinase Kinases
4
2004
134
0.310
Why?
Neoplasms
6
2025
2644
0.310
Why?
Beckwith-Wiedemann Syndrome
1
2008
6
0.310
Why?
Adrenal Gland Neoplasms
2
2014
89
0.300
Why?
Fluorodeoxyglucose F18
1
2009
135
0.300
Why?
Neoplasms, Multiple Primary
1
2008
57
0.290
Why?
Asparaginase
2
1998
30
0.290
Why?
JNK Mitogen-Activated Protein Kinases
5
2004
162
0.290
Why?
Positron-Emission Tomography
1
2009
295
0.280
Why?
MAP Kinase Kinase Kinase 1
3
2005
19
0.280
Why?
Adrenal Cortex Neoplasms
1
2008
63
0.280
Why?
Histiocytosis, Langerhans-Cell
2
2020
38
0.270
Why?
Pancreatitis
2
1998
132
0.270
Why?
Child
24
2025
21968
0.260
Why?
Child, Preschool
18
2025
11069
0.250
Why?
MAP Kinase Kinase Kinase 2
7
2012
12
0.250
Why?
Teratoma
2
2025
114
0.250
Why?
Mast Cells
3
2003
146
0.240
Why?
Nose Neoplasms
1
2025
25
0.240
Why?
Carcinosarcoma
1
2025
21
0.230
Why?
Testicular Neoplasms
2
2017
110
0.230
Why?
Adaptor Proteins, Signal Transducing
4
2003
429
0.230
Why?
Genetic Heterogeneity
1
2025
59
0.230
Why?
Clonal Evolution
1
2025
45
0.230
Why?
Appointments and Schedules
1
2025
89
0.230
Why?
Adolescent
20
2025
21463
0.220
Why?
Paclitaxel
1
2025
227
0.220
Why?
Medical Errors
1
2025
110
0.210
Why?
Fibroblast Growth Factor 2
1
2004
87
0.210
Why?
Catheterization, Central Venous
1
2025
111
0.210
Why?
Biomarkers, Tumor
3
2025
1274
0.210
Why?
Central Nervous System Diseases
1
2024
69
0.200
Why?
Neoplasms, Germ Cell and Embryonal
2
2016
77
0.200
Why?
MAP Kinase Signaling System
3
2008
321
0.200
Why?
Lung Neoplasms
2
2021
2491
0.200
Why?
Neoplasms, Second Primary
1
2024
115
0.200
Why?
Bone Neoplasms
1
2025
248
0.200
Why?
Parental Leave
1
2022
26
0.190
Why?
Single-Cell Analysis
1
2025
310
0.190
Why?
Anemia
1
2023
170
0.190
Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
1999
182
0.190
Why?
Thrombocytopenia
1
2023
199
0.180
Why?
Sarcoma
2
2015
191
0.180
Why?
Pulmonary Blastoma
1
2021
8
0.180
Why?
Tomography, X-Ray Computed
2
2021
2677
0.180
Why?
RNA, Neoplasm
1
2021
82
0.180
Why?
Circulating Tumor DNA
1
2021
34
0.170
Why?
Stem Cell Factor
1
2000
15
0.170
Why?
Pituitary Diseases
1
2020
21
0.170
Why?
Ribonuclease III
1
2021
40
0.170
Why?
Cholestasis
1
2023
232
0.170
Why?
Sertoli-Leydig Cell Tumor
1
2020
8
0.170
Why?
Receptors, IgE
1
2000
45
0.170
Why?
Rhabdomyosarcoma, Embryonal
1
2020
22
0.170
Why?
Fibroblasts
3
2005
989
0.170
Why?
Infant
12
2025
9442
0.170
Why?
DEAD-box RNA Helicases
1
2021
76
0.170
Why?
Pituitary Gland
1
2020
149
0.170
Why?
Lymphohistiocytosis, Hemophagocytic
1
2020
31
0.160
Why?
Humans
39
2025
136783
0.160
Why?
Survival Rate
3
2019
1969
0.160
Why?
Salvage Therapy
2
2025
142
0.150
Why?
Fellowships and Scholarships
1
2022
306
0.150
Why?
Neoplasm Recurrence, Local
1
2025
1055
0.150
Why?
Disease-Free Survival
2
2019
687
0.150
Why?
Proto-Oncogene Proteins B-raf
1
2020
226
0.150
Why?
Polycystic Kidney Diseases
1
2019
76
0.150
Why?
Female
23
2025
72840
0.150
Why?
Male
23
2025
67361
0.140
Why?
Octreotide
1
1998
26
0.140
Why?
Biopsy, Large-Core Needle
1
2017
14
0.140
Why?
Antibodies, Neutralizing
1
2020
282
0.140
Why?
Abdominal Neoplasms
1
2017
39
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2025
1683
0.140
Why?
Cancer Survivors
1
2022
279
0.130
Why?
Cytodiagnosis
1
2017
33
0.130
Why?
Frozen Sections
1
2017
26
0.130
Why?
Seminoma
1
2017
20
0.130
Why?
Interferon-gamma
1
2020
790
0.130
Why?
Quality Improvement
1
2025
1152
0.130
Why?
Cytokines
2
2004
2088
0.130
Why?
Protein Processing, Post-Translational
1
1999
467
0.130
Why?
Tumor Necrosis Factor-alpha
4
2003
1242
0.130
Why?
Enzyme Activation
6
2004
813
0.130
Why?
Retrospective Studies
8
2025
15564
0.120
Why?
Health Planning
1
2015
47
0.120
Why?
Saccharomyces cerevisiae Proteins
1
1999
404
0.120
Why?
Ovarian Neoplasms
1
2020
563
0.110
Why?
Thoracoscopy
1
2014
56
0.110
Why?
Mediastinal Neoplasms
1
2014
45
0.110
Why?
Transcription Factor AP-1
2
2005
92
0.110
Why?
Transition to Adult Care
1
2015
81
0.110
Why?
Genetic Predisposition to Disease
2
2021
2417
0.110
Why?
Arabinonucleosides
1
2013
8
0.110
Why?
Adenine Nucleotides
1
2013
23
0.110
Why?
Xanthogranuloma, Juvenile
1
2013
6
0.110
Why?
Histiocytosis, Sinus
1
2013
8
0.110
Why?
Disease Management
2
2015
623
0.110
Why?
Biopsy
1
2017
1126
0.110
Why?
Carrier Proteins
4
2003
768
0.110
Why?
Ambulatory Care Facilities
1
2015
230
0.100
Why?
Antimetabolites, Antineoplastic
1
2013
94
0.100
Why?
Antibodies, Monoclonal
1
2020
1428
0.100
Why?
Heart Diseases
1
2016
359
0.100
Why?
Hypertrophy, Right Ventricular
1
2012
145
0.090
Why?
Prognosis
5
2025
4018
0.090
Why?
Prevalence
1
2019
2712
0.090
Why?
Diagnostic Imaging
1
2014
331
0.090
Why?
Anesthesia
1
2014
191
0.090
Why?
Gene Expression Regulation
4
2012
2603
0.090
Why?
Receptors, Tumor Necrosis Factor
2
2002
164
0.090
Why?
Signal Transduction
3
2004
5065
0.090
Why?
Program Development
2
2015
365
0.080
Why?
Ventricular Remodeling
1
2012
262
0.080
Why?
Stem Cells
2
2008
590
0.080
Why?
Laparoscopy
1
2014
464
0.080
Why?
Pediatrics
2
2008
1112
0.080
Why?
Subtraction Technique
1
2009
23
0.080
Why?
Primary Health Care
2
2022
1714
0.080
Why?
Young Adult
7
2025
13126
0.080
Why?
Radiopharmaceuticals
1
2009
178
0.080
Why?
Potassium Channels, Voltage-Gated
1
2008
50
0.070
Why?
Myocytes, Cardiac
1
2012
528
0.070
Why?
Adult
7
2025
37616
0.070
Why?
Mutation
4
2025
3953
0.070
Why?
Polymerase Chain Reaction
2
2021
1059
0.070
Why?
Heart Ventricles
1
2012
792
0.070
Why?
Antineoplastic Agents
1
1998
2129
0.070
Why?
Infant, Newborn
4
2023
6046
0.070
Why?
Embryo, Mammalian
2
2005
231
0.070
Why?
Mitogen-Activated Protein Kinase 7
4
2012
21
0.060
Why?
Leukemia
1
2008
238
0.060
Why?
Liver Neoplasms
1
2012
784
0.060
Why?
Risk Assessment
1
2015
3429
0.060
Why?
Near Miss, Healthcare
1
2025
11
0.060
Why?
Hypoxia
1
2012
1107
0.060
Why?
Epidermal Growth Factor
2
2003
174
0.060
Why?
Age Factors
3
2018
3290
0.060
Why?
Cell Line
5
2003
2836
0.060
Why?
Acute Disease
2
1998
1006
0.060
Why?
Education, Medical, Undergraduate
1
2007
186
0.060
Why?
Proto-Oncogene Proteins c-jun
1
2005
55
0.060
Why?
Transcription Factors
2
2021
1714
0.060
Why?
Killer Cells, Natural
1
2008
445
0.060
Why?
Cord Blood Stem Cell Transplantation
1
2005
99
0.060
Why?
SEER Program
2
2016
218
0.060
Why?
Neoplastic Cells, Circulating
1
2025
80
0.060
Why?
MAP Kinase Kinase 4
1
2004
29
0.060
Why?
Phosphorylation
3
2012
1756
0.060
Why?
DNA Copy Number Variations
1
2025
182
0.050
Why?
Antineoplastic Agents, Phytogenic
1
2025
190
0.050
Why?
Genes, jun
1
2003
10
0.050
Why?
Blotting, Western
2
2004
1225
0.050
Why?
Apoptosis
3
2002
2548
0.050
Why?
Myogenic Regulatory Factors
1
2003
57
0.050
Why?
Survival Analysis
2
2018
1319
0.050
Why?
Neoplasm Metastasis
2
2018
654
0.050
Why?
DNA Methylation
1
2008
644
0.050
Why?
Fluorescent Antibody Technique
1
2004
386
0.050
Why?
beta Catenin
1
2025
251
0.050
Why?
Macromolecular Substances
2
2003
229
0.050
Why?
Promoter Regions, Genetic
3
2005
1250
0.050
Why?
Tissue Donors
1
2005
417
0.050
Why?
src-Family Kinases
1
2003
92
0.050
Why?
Sequence Analysis, RNA
1
2025
451
0.050
Why?
Animals
9
2012
36768
0.050
Why?
Mice
6
2012
17731
0.050
Why?
Mice, Knockout
2
2012
2999
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2005
288
0.050
Why?
Recurrence
3
2013
1058
0.050
Why?
Academic Medical Centers
1
2025
497
0.050
Why?
Cell Differentiation
2
2000
1980
0.050
Why?
Survivors
2
2016
487
0.050
Why?
Central Nervous System
1
2024
258
0.050
Why?
Databases, Factual
2
2018
1347
0.050
Why?
Enzyme-Linked Immunosorbent Assay
1
2004
849
0.050
Why?
Cells, Cultured
3
2005
4194
0.050
Why?
Survivorship
1
2022
49
0.050
Why?
Protein-Tyrosine Kinases
2
2008
434
0.040
Why?
Proto-Oncogene Protein c-fli-1
1
2021
24
0.040
Why?
RNA-Binding Protein EWS
1
2021
25
0.040
Why?
Hypertension, Pulmonary
1
2012
1902
0.040
Why?
Kidney Diseases, Cystic
1
2021
24
0.040
Why?
Receptor Aggregation
1
2000
11
0.040
Why?
Tumor Microenvironment
1
2025
671
0.040
Why?
Transcription, Genetic
2
2005
1453
0.040
Why?
Curriculum
1
2007
979
0.040
Why?
Pneumothorax
1
2021
38
0.040
Why?
Translocation, Genetic
1
2021
104
0.040
Why?
Reoviridae
1
2000
37
0.040
Why?
Chemokine CXCL9
1
2020
27
0.040
Why?
Syndrome
1
2021
357
0.040
Why?
Germ-Line Mutation
1
2021
172
0.040
Why?
Mutagenesis, Site-Directed
1
2000
376
0.040
Why?
p38 Mitogen-Activated Protein Kinases
1
2000
282
0.040
Why?
Surveys and Questionnaires
2
2022
5749
0.040
Why?
Mating Factor
1
1999
3
0.040
Why?
Cell Compartmentation
1
1999
52
0.040
Why?
Receptors, Growth Factor
1
1999
55
0.040
Why?
Follow-Up Studies
2
2020
5115
0.040
Why?
Oncogene Proteins, Fusion
1
2021
214
0.040
Why?
Growth Substances
1
1999
147
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2025
1396
0.040
Why?
Insect Proteins
1
1999
39
0.040
Why?
Proto-Oncogene Proteins
1
2002
646
0.040
Why?
TRPP Cation Channels
1
2019
84
0.040
Why?
Fungal Proteins
1
1999
134
0.040
Why?
Transcriptional Activation
1
2000
378
0.040
Why?
Age of Onset
1
2020
518
0.040
Why?
Education, Medical, Graduate
1
2022
481
0.040
Why?
MAP Kinase Kinase 5
3
2003
4
0.040
Why?
Gene Expression Profiling
1
2025
1768
0.040
Why?
Cytoskeleton
1
1999
186
0.040
Why?
Chronic Disease
2
2015
1784
0.040
Why?
Kaplan-Meier Estimate
1
2020
891
0.030
Why?
Membrane Glycoproteins
1
2000
500
0.030
Why?
Dexamethasone
1
2020
377
0.030
Why?
DNA-Binding Proteins
1
2005
1500
0.030
Why?
Combined Modality Therapy
1
2020
1235
0.030
Why?
Mammals
1
1999
283
0.030
Why?
Receptors, Cell Surface
1
2019
386
0.030
Why?
United States
3
2022
14660
0.030
Why?
Drug Therapy, Combination
1
2020
1059
0.030
Why?
Drosophila melanogaster
1
1999
228
0.030
Why?
Hepatoblastoma
1
2017
46
0.030
Why?
Intraoperative Period
1
2017
59
0.030
Why?
Incidence
1
2024
2788
0.030
Why?
Microtubules
1
1999
270
0.030
Why?
Anti-Inflammatory Agents
1
2020
495
0.030
Why?
Epidemiological Monitoring
1
2016
60
0.030
Why?
Stress, Physiological
1
1999
442
0.030
Why?
Caenorhabditis elegans
1
1999
305
0.030
Why?
Time Factors
2
2018
6792
0.030
Why?
Neurilemmoma
1
2014
24
0.030
Why?
Organizational Innovation
1
2015
138
0.030
Why?
Hematopoietic Stem Cell Transplantation
1
2020
615
0.030
Why?
Saccharomyces cerevisiae
1
1999
558
0.030
Why?
Interdisciplinary Communication
1
2015
192
0.030
Why?
Parents
1
2022
1355
0.030
Why?
Peptides
1
1999
980
0.030
Why?
Lymphoma
1
2014
206
0.030
Why?
Reproducibility of Results
1
2021
3272
0.030
Why?
Neoplasm Staging
1
2017
1373
0.020
Why?
MAP Kinase Kinase 7
2
2003
8
0.020
Why?
Logistic Models
1
2018
2060
0.020
Why?
RNA, Messenger
1
2000
2831
0.020
Why?
Analysis of Variance
1
2015
1318
0.020
Why?
Two-Hybrid System Techniques
2
2003
59
0.020
Why?
T-Lymphocytes
1
2000
1998
0.020
Why?
Colorado
2
2015
4491
0.020
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
2
2002
30
0.020
Why?
fas Receptor
2
2002
95
0.020
Why?
Program Evaluation
1
2015
886
0.020
Why?
Caspases
2
2002
247
0.020
Why?
Treatment Outcome
2
2020
10764
0.020
Why?
Aged
2
2022
23729
0.020
Why?
Inflammation Mediators
1
2012
514
0.020
Why?
Transfection
2
2003
945
0.020
Why?
Receptor, IGF Type 1
1
2008
65
0.020
Why?
Ultrasonography
1
2012
751
0.020
Why?
Chemistry, Pharmaceutical
1
2008
105
0.020
Why?
Practice Patterns, Physicians'
1
2017
1294
0.020
Why?
Drug Design
1
2008
166
0.020
Why?
Bone Marrow Transplantation
1
2008
286
0.020
Why?
Schools, Medical
1
2007
146
0.020
Why?
Pancreatic Neoplasms
1
2014
931
0.020
Why?
Clinical Clerkship
1
2007
98
0.020
Why?
Medical Oncology
1
2008
290
0.020
Why?
Vascular Endothelial Growth Factor A
1
2008
544
0.020
Why?
Histocompatibility Testing
1
2005
126
0.020
Why?
Protein Binding
2
2003
2223
0.010
Why?
Fos-Related Antigen-2
1
2005
1
0.010
Why?
Oligonucleotide Probes
1
2005
51
0.010
Why?
Prospective Studies
1
2017
7583
0.010
Why?
Urokinase-Type Plasminogen Activator
1
2005
29
0.010
Why?
Tetradecanoylphorbol Acetate
1
2005
150
0.010
Why?
Middle Aged
2
2017
33200
0.010
Why?
Dimerization
1
2005
198
0.010
Why?
Transplantation, Homologous
1
2005
415
0.010
Why?
Faculty, Medical
1
2007
282
0.010
Why?
Aged, 80 and over
1
2016
7569
0.010
Why?
Flow Cytometry
1
2008
1181
0.010
Why?
MEF2 Transcription Factors
1
2003
61
0.010
Why?
Clinical Trials as Topic
1
2008
1043
0.010
Why?
Graft vs Host Disease
1
2005
249
0.010
Why?
Mink
1
2003
12
0.010
Why?
Osmolar Concentration
1
2003
170
0.010
Why?
Amino Acid Motifs
1
2003
225
0.010
Why?
Disease Models, Animal
1
2012
4279
0.010
Why?
Multivariate Analysis
1
2005
1513
0.010
Why?
Cell Nucleus
1
2005
614
0.010
Why?
Caspase 3
1
2002
246
0.010
Why?
Models, Biological
1
2008
1769
0.010
Why?
Base Sequence
1
2005
2180
0.010
Why?
MAP Kinase Kinase Kinase 3
1
2000
4
0.010
Why?
Fas-Associated Death Domain Protein
1
2000
9
0.010
Why?
Caspase 8
1
2000
48
0.010
Why?
Caspase 9
1
2000
57
0.010
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2000
51
0.010
Why?
COS Cells
1
2000
188
0.010
Why?
Phosphatidylinositol 3-Kinases
1
2002
365
0.010
Why?
Antigen-Presenting Cells
1
2000
156
0.010
Why?
Caspase Inhibitors
1
2000
81
0.010
Why?
Oxidants
1
2000
110
0.010
Why?
Molecular Sequence Data
1
2005
2903
0.010
Why?
Proto-Oncogene Proteins c-akt
1
2002
436
0.010
Why?
Apoptosis Regulatory Proteins
1
2000
188
0.010
Why?
Hydrogen Peroxide
1
2000
320
0.010
Why?
Mitosis
1
1999
193
0.010
Why?
Epithelial Cells
1
2003
1093
0.010
Why?
Lymphocyte Activation
1
2000
1150
0.010
Why?
Oxidative Stress
1
2003
1309
0.010
Why?
Kidney
1
2003
1463
0.010
Why?
Garrington's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)